IFN circuit. Taken together these findings suggest that release of IFN is a frequent event among transformed nonhaemopoietic cells, and that self-produced IFN contributes to the regulation of MHC antigen levels in solid tumours.
The expression of Major Histocompatibility Complex (MHC) membrane glycoproteins is frequently impaired in tumours (Tanaka et al., 1988; Elliott et al., 1989; Gopas et al., 1989) . From the analysis of some published reports we estimate that up to 50% of all human tumours may have alterations of class I MHC glycoproteins expression with respect to their normal counterparts.
The dynamic analysis of the in vitro behaviour of MHC glycoprotein-positive tumour cells reveals an additional type of MHC instability: some cell lines show a progressive decrease in MHC expression during in vitro growth, while others maintain stable MHC glycoprotein levels. In murine model systems it has been shown that a high MHC glycoprotein expression can be induced either by in vitro treatment with interferons (IFN) (Tanaka et al., 1988) or by in vivo transplant (Ostrand-Rosenberg & Cohan, 1981; Lollini et al., 1985) . We have suggested that re-expression of MHC products during in vivo culture might be caused by IFN produced by the host (Lollini et al., 1985) . An adjunct to this hypothesis is that tumour cells retaining MHC expression in vitro should be independent of host-derived IFN.
The present study was set up to ascertain the frequency of IFN producers in a panel of murine nonhaemopoietic H-2b transformed cells of diverse origin, and to investigate whether MHC glycoprotein expression was linked to IFN production, possibly through autocrine circuits.
Materials and methods

Cells
The cells used in this study are listed in Table I . The cultures were routinely maintained in Dulbecco's MEM (DMEM) supplemented with 10% Fetal Calf Serum (FCS) and antibiotics (10OUml1' penicillin and 100 Igmlm1 streptomycin) at 37'C in a 5% CO2 humidified atmosphere. All media components were purchased from GIBCO, Paisley, UK. Cell cultures, routinely monitored for mycoplasma contamination by Hoechst 33258 staining (Chen, 1977) 
Results
Expression of H-2Kb and Db glycoproteins in cultured cells
The expression of H-2 class I glycoproteins was investigated in 11 cell lines of the H-2b haplotype, derived from distinct tumour histotypes (carcinomas, sarcomas, melanoma) or transformed by different agents (see Table I ). Flow cytometric analysis (Figure 1) 
Discussion
In vitro cultured cells frequently show considerable variations in their expression of MHC gene products (Carbone et al., 1978; Finn et al., 1978; Nanni et al., 1983) . We have shown here that, in a panel of murine transformed H-2b cells of diverse origin, production of IFN was a frequent event: nine of eleven cell lines released IFN-a/P in the culture medium. . However, we cannot rule out the possibility that other factors might also be involved. The highest IFN release was observed among fibrosarcomas and transformed fibroblasts, while also some nonmesenchymal cell lines release a detectable IFN activity. A high IFN production did not appear to be associated with a slower in vitro growth rate. It is interesting to note that in vivo tumorigenicity did not correlate with IFN production: on the basis of IFN units found in their supernatants one cannot distinguish metastatic fibrosarcomas, like MN/MCA1 and R80/17, and nontumorigenic fibroblasts like C57SV.
Presently we do not know whether a sustained IFN release is maintained in vivo by tumorigenic cells. A considerable quantitative heterogeneity was observed within lines: for example in fibrosarcomas two log decades separated MN/ MCA1 and B6.3. Cloning experiments and selection of metastatic variants will show whether clonal heterogenity is present in vitro and whether selective advantages or disadvantages are conferred in vivo by IFN production.
It has been reported that the MHC glycoprotein expression by human tumours correlates with the extent of lymphocytic infiltrate (Maudsley & Pound, 1991) . It is reasonable to assume that tumour-infiltrating cells act as a source of IFNs and of other lymphokines influencing MHC genes. Here we have investigated only phenomena taking place in vitro, but we can hypothesise that tumours producing IFN should have MHC glycoprotein levels independent of their infiltrate. It must be kept in mind, however, that the in vivo production of IFN by the tumour cells might vary depending on growth rate, nutritional status, and also on the interaction with other IFN-producing cells such as macrophages and lymphoid cells: we have previously shown that in vivo the antigenic distance between tumour and host can influence tumour H-2 expression, probably through IFN-i released by T cells (Lollini et al., 1985) . Interaction with other cytokines might also affect MHC expression.
The determination of IFN production by tumour cells might represent a useful adjunct to the study of MHC expression in human neoplasms. Mesenchymal tumours appear to be good candidates to test this hypothesis.
